Contrast-enhanced Ultrasound Improves Technical Sufficiency of Fine-needle Aspiration in Suspicious Thyroid Nodules

Fu, MD Ying; Tan, MD Shi; Cui, MD LiGang; Mei, MD Fang

doi:10.37015/AUDT.2021.200063

ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY >

2021 , Vol. 5 >Issue 3: 219 - 225

DOI: https://doi.org/10.37015/AUDT.2021.200063

Original Researchs

Contrast-enhanced Ultrasound Improves Technical Sufficiency of Fine-needle Aspiration in Suspicious Thyroid Nodules

Fu, MD Ying ,
Tan, MD Shi ,
Cui, MD LiGang ,
Mei, MD Fang

Expand

^aDepartment of Ultrasound, Peking University Third Hospital, Beijing, China
^bDepartment of Pathology, Peking University Third Hospital, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China

Received date: 2020-10-26

Revised date: 2020-12-08

Online published: 2021-08-31

Fold

Abstract

Objectives: To evaluate contrast-enhanced ultrasound (CEUS) for guiding fine-needle aspiration (FNA) of suspicious thyroid nodules to obtain sufficient biopsy specimens.
Methods: A total of 236 uncertain thyroid nodules detected in 228 patients from October 2016 to March 2017 were retrospectively reviewed and analyzed in this study. Overall, 117 patients underwent CEUS-guided FNA, and 111 patients underwent ultrasound (US)-guided FNA. The target for aspiration was only at the enhanced area in the CEUS group. In the US-guided group, aspiration was conducted within the nodule at various angles and areas. The final cytopathologic findings were reported using the Bethesda criteria. The inadequacy, indeterminacy, malignancy, and benignity rates of FNA specimens were compared between two groups.
Results: There were no significant differences in age, sex, or nodule size between the two groups. The inadequacy rate in the CEUS group was significantly lower than that in the US group (P = 0.008). Twenty-two benign nodules were diagnosed using CEUS-guided FNA, whereas seven were diagnosed using US-guided FNA (P = 0.006). The indeterminacy and malignancy rates were similar for both groups.
Conclusions: CEUS-guided FNA improves the diagnostic success rate and reduces uncertainty by facilitating accurate biopsy of suspected thyroid nodules with microcirculation perfusion imaging.

Key words： Thyroid; Neoplasm; Ultrasound; Contrast agent; Fine-needle aspiration

Cite this article

Fu, MD Ying , Tan, MD Shi , Cui, MD LiGang , Mei, MD Fang . Contrast-enhanced Ultrasound Improves Technical Sufficiency of Fine-needle Aspiration in Suspicious Thyroid Nodules[J]. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY, 2021 , 5(3) : 219 -225 . DOI: 10.37015/AUDT.2021.200063

References

[1]	Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedüs L, et al. AACE/ACE/AME Task force on thyroid nodules. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules--2016 Update. Endocr Pract 2016; 22:622-639.
[2]	Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26:1-133.
[3]	Lee YH, Baek JH, Jung SL, Kwak JY, Kim JH, Shin JH, et al. Ultrasound-guided fine needle aspiration of thyroid nodules: a consensus statement by the Korean society of thyroid radiology. Korean J Radiol 2015; 16:391-401.
[4]	Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol 2012; 56:333-339.
[5]	Alexander EK, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, et al. Assessment of non-diagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab 2002; 87:4924-4927.
[6]	Choi SH, Han KH, Yoon JH, Moon HJ, Son EJ, Youk JH, et al. Factors affecting inadequate sampling of ultrasound guided fine-needle aspiration biopsy of thyroid nodules. Clin Endocrinol (Oxf) 2011; 74:776-782.
[7]	Fadda G, Rossi ED. Liquid-based cytology in fine-needle aspiration biopsies of the thyroid gland. Acta Cytol 2011; 55:389-400.
[8]	Khadra H, Bakeer M, Hauch A, Hu T, Kandil E. Is vascular flow a predictor of malignant thyroid nodules? a meta-analysis. Gland Surg 2016; 5:576-582.
[9]	Xia HS, Wang X, Ding H, Wen JX, Fan PL, Wang WP. Papillary breast lesions on contrast-enhanced ultrasound: morphological enhancement patterns and diagnostic strategy. Eur Radiol 2014; 24:3178-3190.
[10]	Müller-Peltzer K, Rübenthaler J, Reiser M, Clevert DA. Contrast-enhanced ultrasound (CEUS) of the liver: Critical evaluation of use in clinical routine diagnostics. Radiologe 2017; 57:348-355.
[11]	Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004; 51 Suppl: S19-23.
[12]	Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14:587-595.
[13]	Ali SZ, Cibas ES. The bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2009; 132:658-665.
[14]	Rossi ED, Bizzarro T, Martini M, Straccia P, Lombardi CP, Pontecorvi A, et al. The role of fine-needle aspiration in the thyroid nodules of elderly patients. Oncotarget 2016; 7:11850-11859.
[15]	Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993; 118:282-289.
[16]	Espinosa De Ycaza AE, Lowe KM, Dean DS, Castro MR, Fatourechi V, Ryder M, et al. Risk of malignancy in thyroid nodules with non-diagnostic fine-needle aspiration: a retrospective cohort study. Thyroid 2016; 26:1598-1604.
[17]	Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsøe CP, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 2013; 39:187-210.
[18]	Wu W, Chen MH, Yin SS, Yan K, Fan ZH, Yang W, et al. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. AJR Am J Roentgenol 2006; 187:752-761.
[19]	Eso Y, Takai A, Takeda H, Matsumoto T, Lee M, Inuzuka T, et al. Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions. Eur J Gastroenterol Hepatol 2016; 28:1462-1467.
[20]	Li F, Luo H. Comparative study of thyroid puncture biopsy guided by contrast-enhanced ultrasonography and conventional ultrasound. Exp Ther Med 2013; 5:1381-1384.
[21]	Choi SH, Han KH, Yoon JH, Moon HJ, Son EJ, Youk JH, et al. Factors affecting inadequate sampling of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules. ClinEndocrinol (Oxf) 2011; 74:776-782.
[22]	Lacout A, Chevenet C, Marcy PY. Mummified thyroid syndrome. AJR Am J Roentgenol 2016; 206:837-845.
[23]	Cibas ES, Ali SZ. The 2017 bethesda system for reporting thyroid cytopathology. Thyroid 2017; 27:1341-1346.

Options

Outlines

模态框（Modal）标题

Abstract

Cite this article

References